CNBX Pharmaceuticals Market Cap

CNBX Pharmaceuticals has a market cap or net worth of $245.15 thousand as of April 29, 2026. Its market cap has decreased by -4.74% in one year.

Market Cap

245.15K

Enterprise Value

1.40M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.00

Market Cap Chart

Since May 20, 2011, CNBX Pharmaceuticals's market cap has increased from 238.06K to 245.15K, an increase of 2.98%. That is a compound annual growth rate of 0.20%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	367.73K	22.06%
Dec 31, 2025	301.28K	30.86%
Dec 31, 2024	230.22K	-47.89%
Dec 29, 2023	441.78K	-81.12%
Dec 30, 2022	2.34M	-79.95%
Dec 31, 2021	11.67M	-58.56%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sorrento Therapeutics	489.34K
EV Biologics	511.27K
Regenerative Medical Technology Group	525.56K
Altamira Therapeutics	457.24K
Bio-Path Holdings	579.77K
Eloxx Pharmaceuticals	608.63K
Actavia Life Sciences	385.91K
Emmaus Life Sciences	638.71K

Market Cap Rankings